Dr. Nagi El-Saghir summarizes key advances from SABCS 2025, highlighting results from HER2CLIMB-05 and evolving treatment options for metastatic HER2-positive breast cancer. He reviews maintenance strategies, T-DXd combinations, and how new regimens are improving outcomes.
